Published Technical Disclosure Archive

Advanced Prostate Cancer Treatment Systems

Publication ID: 24-11857243_0010_PTD
Published: November 07, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Advanced Prostate Cancer Treatment Systems,” Published Technical Disclosure No. 24-11857243_0010_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857243_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,243.

Summary of the Inventive Concept

Next-generation prostate cancer treatment systems utilizing wearable, implantable, and robotic devices with AI-powered temperature control, real-time imaging, and data analytics for personalized and effective treatment

Background and Problem Solved

The original patent for treating prostate cancer with heated condensable vapor has limitations in terms of invasiveness, treatment efficacy, and patient outcomes. The new inventive concept addresses these limitations by introducing advanced, minimally-invasive devices and AI-driven systems that provide real-time feedback, personalized treatment plans, and enhanced patient outcomes.

Detailed Description of the Inventive Concept

The new inventive concept comprises a range of devices and systems that leverage cutting-edge technologies such as shape-memory alloy needles, high-frequency ultrasonic vapor generators, and machine learning algorithms. These devices and systems enable trans-urethral, trans-perineal, or trans-rectal access to the prostate, allowing for targeted and effective treatment of prostate cancer. The AI-powered temperature control system ensures precise and real-time control of vapor delivery, while the data analytics module tracks treatment efficacy and patient outcomes.

Novelty and Inventive Step

The new claims introduce novel and non-obvious advancements in prostate cancer treatment, including wearable and implantable devices, robotic vapor delivery systems, and AI-driven temperature control and data analytics. These advancements provide a paradigm shift in the treatment of prostate cancer, offering improved efficacy, reduced invasiveness, and enhanced patient outcomes.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different vapor delivery mechanisms, such as microwave or radiofrequency ablation, or the integration of additional imaging modalities, such as MRI or CT scans. Variations of the inventive concept could also include the development of hybrid devices that combine multiple treatment modalities or the creation of personalized treatment plans based on genetic profiling.

Potential Commercial Applications and Market

The advanced prostate cancer treatment systems have significant commercial potential in the medical device industry, with a target market of urologists, oncologists, and healthcare providers. The market potential is substantial, with an estimated global value of over $10 billion by 2025.

CPC Classifications

SectionClassGroup
A A61 A61B18/042
A A61 A61B8/0841
A A61 A61B18/04
A A61 A61B2018/00005
A A61 A61B2018/00011
A A61 A61B2018/00017
A A61 A61B2018/00023
A A61 A61B2018/00101
A A61 A61B2018/00547
A A61 A61B2018/00577
A A61 A61B2018/00642
A A61 A61B2018/00702
A A61 A61B2018/00744
A A61 A61B2018/00791
A A61 A61B2018/00821
A A61 A61B2018/044
A A61 A61B2018/048
A A61 A61B2090/378
A A61 A61B2090/3784
A A61 A61B2218/007

Field of Art

Medical device technology for minimally invasive cancer treatment, specifically focused on prostate cancer interventions involving thermal ablation techniques, requiring expertise in medical imaging, interventional oncology, and thermal energy delivery systems

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or interventional radiologist with advanced degrees, expertise in medical device design, knowledge of thermal ablation techniques, understanding of minimally invasive surgical technologies, and familiarity with emerging cancer treatment methodologies

Obviousness Rationale

A person having ordinary skill would recognize that the PTD represents predictable technological extensions of the source patent's core vapor-based prostate cancer treatment methodology. The disclosed variations introduce incremental improvements in delivery mechanisms, control systems, and patient-specific customization that would be considered routine engineering adaptations. The fundamental concept of targeted vapor-based prostate tissue ablation remains consistent across both the source patent and the PTD, with the new disclosure representing natural technological progression.

Obvious Combinations & Variations

Source Patent Element
Vapor delivery needle inserted into prostate peripheral zone for targeted ablation
PTD Variation
Shape-memory alloy needle with trans-urethral, trans-perineal, and trans-rectal access options
Obviousness Reasoning
Modifying needle design and access routes represents a predictable design variation within known interventional techniques, with a finite set of anatomically feasible approaches
Source Patent Element
Vapor delivery for localized prostate tissue treatment
PTD Variation
AI-powered temperature control and real-time data analytics for treatment optimization
Obviousness Reasoning
Integrating computational monitoring and control systems with existing medical intervention techniques is a known approach for improving precision and patient outcomes
Source Patent Element
Targeted thermal ablation of prostate tissue
PTD Variation
Multimodal imaging techniques creating 3D prostate models for customized treatment planning
Obviousness Reasoning
Using advanced imaging for treatment personalization represents a standard progression in medical intervention technologies, applying known computational techniques to existing treatment methodologies
Source Patent Element
Vapor-based prostate cancer treatment method
PTD Variation
Wearable and implantable devices with wireless monitoring capabilities
Obviousness Reasoning
Miniaturization and remote monitoring of medical devices are well-established technological trends, representing predictable extensions of existing intervention technologies
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857243 and the disclosed technological variations, a person having ordinary skill in the art would find the claimed innovations obvious and lacking inventive step. The incremental advancements in vapor delivery, computational control, and patient-specific treatment methodologies represent predictable technological progressions that do not rise to the level of non-obvious innovation required for patent protection.

Original Patent Information

Patent NumberUS 11,857,243
TitleSystems and methods for treating prostate cancer
Assignee(s)Boston Scientific Scimed, Inc.